These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8958267)

  • 41. Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.
    Fuchinoue S; Sawada T; Tsuji K; Kai K; Tojimbara T; Nakajima I; Shiraga H; Ito K; Teraoka S
    Transplantation; 2002 Mar; 73(6):948-52. PubMed ID: 11923698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroid withdrawal after renal transplantation: a retrospective cohort study.
    Haller MC; Kammer M; Kainz A; Baer HJ; Heinze G; Oberbauer R
    BMC Med; 2017 Jan; 15(1):8. PubMed ID: 28077142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants.
    Gulanikar AC; MacDonald AS; Sungurtekin U; Belitsky P
    Transplantation; 1992 Feb; 53(2):323-8. PubMed ID: 1738926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sirolimus permits steroid withdrawal from a cyclosporine regimen.
    Mahalati K; Kahan BD
    Transplant Proc; 2001; 33(1-2):1270. PubMed ID: 11267287
    [No Abstract]   [Full Text] [Related]  

  • 50. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.
    Krämer BK; Krüger B; Mack M; Obed A; Banas B; Paczek L; Schlitt HJ
    Transplant Proc; 2005 May; 37(4):1789-91. PubMed ID: 15919467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withdrawal of steroids after renal transplantation--clinical predictors of outcome.
    Hricik DE; Whalen CC; Lautman J; Bartucci MR; Moir EJ; Mayes JT; Schulak JA
    Transplantation; 1992 Jan; 53(1):41-5. PubMed ID: 1733083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful steroid withdrawal half a year after kidney transplantation.
    Yagisawa T; Nakada T; Hiromasa Y; Kaneko H; Tomaru M; Suzuki Y; Iijima Y
    Int Urol Nephrol; 1995; 27(4):495-501. PubMed ID: 8586526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era.
    Ingulli E; Tejani A; Markell M
    Transplantation; 1993 May; 55(5):1029-33. PubMed ID: 8497876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results.
    Rama I; Cruzado JM; Gil-Vernet S; Torras J; Serón D; Castelao AM; Ibernón M; Bestard O; Grinyó JM
    Transplantation; 2005 Jul; 80(2):164-8. PubMed ID: 16041259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
    Jain A; Kashyap R; Marsh W; Rohal S; Khanna A; Fung JJ
    Transplantation; 2001 Apr; 71(8):1102-6. PubMed ID: 11374410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.
    Rajab A; Pelletier RP; Henry ML; Ferguson RM
    Clin Transplant; 2006; 20(5):537-46. PubMed ID: 16968478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.